About tafamidis
Transthyretin stabilizer
Used for
- Treats transthyretin amyloid cardiomyopathy in adults.
Usual adult dose
61 mg by mouth once daily for transthyretin amyloid cardiomyopathy.
Common side effects
Important warnings
- Not for treating hereditary transthyretin amyloid polyneuropathy.
- May cause fetal harm; pregnancy testing and contraception are recommended during treatment.
Pregnancy
May cause fetal harm. Human pregnancy information is limited.
Breastfeeding
It is unknown whether tafamidis passes into breast milk; effects on infants are unknown.
Interactions
- Tafamidis may increase blood levels of BCRP substrate medicines, such as rosuvastatin.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.